Making the Ordinary, Extraordinary Next Generation TCRs for Precision Immunotherapies About Medigene Medigene is an immuno-oncology platform company dedicated to developing T cell receptor (TCR)-guided therapiesto effectively eliminate cancer. Its End-to-End Platform generates optimal 3S (sensitive, specific and safe) T cellreceptors with unique and distinctive attributes that are utilized in multiple therapeutic modalities such as ... Read more
